SA PRO
Free Account
X4 Pharmaceuticals, Inc.XFORNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 5, 2025Stifel Nicolaus
X4 Pharmaceuticals price target raised to $10 from $7.50 at Stifel
Target:$10.00
+163.2%from $3.80
Nov 5, 2025Stifel Nicolaus
X4 Pharmaceuticals (XFOR) PT Lowered to $7.50 at Stifel
Target:$7.50
+108.6%from $3.60
Aug 29, 2025Stifel Nicolaus
X4 Pharmaceuticals price target lowered to $9 from $30 at Stifel
Target:$9.00
+132.8%from $3.87
Aug 13, 2025H.C. Wainwright
X4 Pharmaceuticals price target lowered to $3.50 from $7 at H.C. Wainwright
Target:$3.50
+35.7%from $2.58
Dec 22, 2022Cantor Fitzgerald
Cantor Fitzgerald Initiates Coverage On X4 Pharmaceuticals with Overweight Rating, Announces Price Target of $3
Target:$3.00
+253.0%from $0.85
Dec 11, 2022Piper Sandler
X4 Pharmaceuticals initiated with an Overweight at Piper Sandler
Target:$3.00
+222.6%from $0.93
Nov 30, 2022H.C. Wainwright
HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5
Target:$5.00
+170.3%from $1.85

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance